Myriad Genetics | MYGN - Cost Of Sales


Myriad Genetics reported $63M in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
Agilent USD 836M 9M Jun/2026
Becton, Dickinson and Co. USD 2.67B 108M Jun/2026
Bio-Rad Laboratories USD 305.2M 22.5M Jun/2026
Bruker USD 422.5M 21.1M Jun/2026
Danaher USD 2.65B 294M Jun/2026
Illumina USD 389M 19M Jun/2026
J&J USD 8B 67M Jun/2026
Mettler Toledo International USD 396.52M 14.4M Jun/2026
Myriad Genetics USD 63M 1.1M Dec/2025
OraSure Technologies USD 15.43M 113K Dec/2025
Pacific Biosciences Of California USD 28.9M 10M Dec/2025
Quest Diagnostics USD 2.05B 64M Jun/2026
Quidel USD 407M 486.5M Jun/2026
Repligen USD 94.09M 8.12M Jun/2026
Revvity USD 312.82M 10.64M Jun/2026
Standard Biotools USD 9.84M 2.58M Mar/2026
Thermo Fisher Scientific USD 7.54B 577M Jun/2026
Veracyte USD 42.19M 3.7M Jun/2026
Waters USD 1.16B 430M Jun/2026